Inventor · disambiguated record
Denis Severini
Also filed as: SEVERINI DENIS
1 granted patent·14 pending applications·139 citations·filing 2003–2022
57Inventor score
Top patents by PatentIndex Score
15 records- 0197US7045620B2Polymorphous forms of rifaximin, processes for their production and use thereof in medicinal preparationsALFA WASSERMANN SPA·Filed 2003·Granted May 16, 2006·139 cites·20 claims
- 0280US2022127283A1Polymorphic forms alpha, beta and gamma of rifaximinALFASIGMA SPA·Filed 2022·Application pending·0 cites
- 0373US2020339599A1Polymorphic forms alpha, beta and gamma of rifaximinALFASIGMA SPA·Filed 2020·Application pending·0 cites
- 0473US2019263829A1Polymorphic forms alpha, beta and gamma of rifaximinALFASIGMA SPA·Filed 2019·Application pending·0 cites
- 0573US2020339600A1Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximinALFASIGMA SPA·Filed 2020·Application pending·0 cites
- 0672US2015175627A1Polymorphic forms alpha, beta and gamma of rifaximinALFA WASSERMANN SPA·Filed 2014·Application pending·0 cites
- 0771US2019263830A1Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximinALFASIGMA SPA·Filed 2019·Application pending·0 cites
- 0870US2019135831A1Polymorphic forms alpha, beta and gamma of rifaximinALFASIGMA SPA·Filed 2018·Application pending·0 cites
- 0968US2019135830A1Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximinALFASIGMA SPA·Filed 2018·Application pending·0 cites
- 1067US2018065987A1Polymorphic forms alpha, beta and gamma of rifaximinALFA WASSERMANN SPA·Filed 2017·Application pending·0 cites
- 1167US2015182508A1Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximinALFA WASSERMANN SPA·Filed 2014·Application pending·0 cites
- 1266US2017210758A1Polymorphic forms alpha, beta and gamma of rifaximinALFA WASSERMANN SPA·Filed 2016·Application pending·0 cites
- 1365US2018065988A1Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximinALFA WASSERMANN SPA·Filed 2017·Application pending·0 cites
- 1463US2017210757A1Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximinALFA WASSERMANN SPA·Filed 2016·Application pending·0 cites
- 1557US2022119410A1Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximinALFASIGMA SPA·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Denis Severini files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →